Literatur
-
1
AD2000 Collaborative Group. Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial.
Lancet.
2004;
363
2105-2115
-
2
Correspondence und Authors Reply siehe .
Lancet.
2004;
364
1213-1217
-
3
Pillen zum Vergessen.
DER SPIEGEL.
2004;
33
118-119
-
4 http://www.kompetenznetz-demenzen.de/media/presse/PM_KND_-_AD2000_01.pdf.
-
5
Fritze J .
Gastpar M .
Demenzkranke bitte nicht diskriminieren.
Psychoneuro.
2004;
30
512-513
-
6
Maelicke A .
Langzeitbehandlung bei Demenz vom Alzheimer-Typ (AD2000-Studie).
Psychoneuro.
2004;
30
514-516
-
7
Letters .
Effectiveness of rivastigmine in Alzheimers disease.
BMJ.
2000;
320
511
-
8
Cohen R. .
Statistical Power Analysis for the Behavioral Sciences.
New York: Erlbaum.
1998;
-
9
Winblad B .
Jelic V .
Long-term treatment of Alzheimer's disease: efficacy and safety of acetylcholinesterase inhibitors.
Alzheimer Dis Assoc Disord .
2004;
18, Suppl 1
S2-S8
-
10
Cummings JL .
Drug therapy: Alzheimers disease.
N Engl J Med .
2004;
351
56-67
-
11
Geldmacher AS .
Provenzano G .
McRae T .
Ieni JR .
Donepezil is associated with delayed nursing home placement in patients with Alzheimers disease.
J Am Geriatr Soc.
2004;
51
937-944
-
12 http://www.alzforum.org/new/detail.asp?id=1038.
-
13
Schneider LS .
AD 2000: donepezil in Alzheimers disease.
Lancet.
2004;
363
2100-2101
-
14
Schneider LS .
Olin JT .
Lyness SA .
Chui HC .
Eligibility of Alzheimers disease clinic patients for clinical trials.
J Am Geriatr Soc.
2004;
45
923-928
-
15
Rogers SL .
Doody RS .
Pratt RD .
Ieni JR .
Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: final analysis of a US multicentre open-label study.
Eur Neuropsychopharmacol .
2000;
10
195-203
-
16
Finucane TE .
Another advertisement for Donepezil.
J Am Geriatr Soc .
2004;
52
843
-
17
Karlawish JHT .
Donepezil delay to nursing home placement study is flawed.
J Am Geriatr Soc .
2004;
52
845
-
18 Zu der uneasy alliance von Pharmaindustrie und Forschung und ihrer vielfältigen Verästelung vgl. zur Einführung die Arbeiten der langjährigen Herausgeberin des New England Journal of Medicine Marcia Angell und von Thomas Bodenheimer: Angell M. Is academic medicine for sale? N Engl J Med 2000; 342: 1516-1518 Angell M. The Truth About the Drug Companies. How they deceive us and what to do about it. New York: Random House, 2004 Bodenheimer T. Uneasy alliance - Clinical investigators and the pharmaceutical industry. N .
Dipl.-Psych. Dr. Wolfgang Kaiser
VIVANTES Klinikum Spandau
Abteilung für Psychiatrie und Psychotherapie Psychiatrische Institutsambulanz
Griesingerstraße 27-32
13589 Berlin
Email: wkaiser@gmx.net
